NervGen Pharma Corp.
Ownership
Ownership Structure
Who owns NervGen Pharma Corp. (NGEN)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 88.6% of the shares are freely tradable; institutional investors hold 5.6%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Empery Asset Management, LP | 3.72 | 4,000,000 | +0.0 | 06/30/2026 |
| Rock Springs Capital Management LP | 1.12 | 1,208,231 | +0.0 | 06/30/2026 |
| Dafna Capital Management LLC | 0.98 | 1,050,000 | +0.0 | 06/30/2026 |
| PFG Investments, LLC | 0.20 | 217,500 | +8.2 | 06/30/2026 |
| Bank of America Corp | 0.19 | 200,656 | +0.0 | 03/31/2026 |
| Marshall Wace Asset Management Ltd | 0.19 | 200,359 | +0.0 | 03/31/2026 |
| Royal Bank of Canada | 0.16 | 171,961 | +0.0 | 03/31/2026 |
| Quadrature Capital Limited | 0.13 | 134,518 | +0.0 | 06/30/2026 |
| Bank of Montreal | 0.07 | 78,394 | +24.6 | 06/30/2026 |
| Integrated Wealth Concepts LLC | 0.07 | 74,215 | -14.5 | 06/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.